Suppr超能文献

九九小儿感冒颗粒对甲型流感病毒感染小鼠肺肠组织的保护作用。

The protective effect of 999 XiaoErGanMao granules on the lungs and intestines of influenza A virus-infected mice.

机构信息

Department of Biological Medicines & Shanghai Engineering Research Center of ImmunoTherapeutics, School of Pharmacy, Fudan University, Shanghai, China.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd, Shenzhen, China.

出版信息

Pharm Biol. 2023 Dec;61(1):630-638. doi: 10.1080/13880209.2023.2195884.

Abstract

CONTEXT

Gastrointestinal symptoms are a common complication of influenza virus infection in children, which the gut-lung axis become involved in its biological progress. The protective effect of 999 XiaoErGanMao granules (XEGMG) on multi-organ injury in viral pneumonia remains unclear.

OBJECTIVE

To investigate the therapeutic effect of XEGMG on lungs and intestines injury in A/FM/1/47 (H1N1) influenza virus-infected mice.

MATERIALS AND METHODS

Male BALB/c mice were infected with the 2LD H1N1 influenza virus and then treated with XEGMG (6 or 12 g/kg) intragastrically once a day for 4 days. The lung and colon samples were then collected for pathological observation, and assays for inflammatory cytokines and intestinal barrier. Mouse feces were collected to evaluate the intestinal microbiota.

RESULTS

Treating with XEGMG (12 g/kg) can mitigate body weight loss caused by 2LD H1N1 infection. It can also reduce lung index and pathological damage with the decreased inflammatory cytokines such as IL-6 and IL-1β. Furthermore, XEGMG (12 g/kg) can maintain the goblet cell number in the colons to protect the intestinal barrier and regulate the major flora such as Firmicutes, Bacteroidetes, and Muribaculaceae back to normal. Meanwhile, the expression of IL-17A in the colon tissues was significantly lower in the group of XEGMG (6, 12 g/kg) compared to H1N1 group.

DISCUSSION AND CONCLUSIONS

XEGMG can protect against H1N1 invasion involved in gut-lung axis regulation. The results provide new evidence for the protective effect of XEGMG, which is beneficial to vulnerable children.

摘要

背景

胃肠道症状是儿童流感病毒感染的常见并发症,其中肠道-肺部轴参与其生物学进程。999 小儿感冒颗粒(XEGMG)对病毒性肺炎多器官损伤的保护作用尚不清楚。

目的

探讨 XEGMG 对 A/FM/1/47(H1N1)流感病毒感染小鼠肺肠损伤的治疗作用。

材料和方法

雄性 BALB/c 小鼠感染 2LD H1N1 流感病毒,然后每天经胃给予 XEGMG(6 或 12g/kg)治疗 4 天。然后收集肺和结肠样本进行病理观察,并检测炎症细胞因子和肠道屏障。收集小鼠粪便评估肠道微生物群。

结果

用 XEGMG(12g/kg)治疗可减轻 2LD H1N1 感染引起的体重减轻。还可以减少肺指数和病理损伤,降低白细胞介素 6(IL-6)和白细胞介素 1β(IL-1β)等炎症细胞因子。此外,XEGMG(12g/kg)可以维持结肠中的杯状细胞数量,保护肠道屏障,并使厚壁菌门、拟杆菌门和 Muribaculaceae 等主要菌群恢复正常。同时,XEGMG(6、12g/kg)组结肠组织中 IL-17A 的表达明显低于 H1N1 组。

讨论和结论

XEGMG 可防止 H1N1 侵袭,涉及肠道-肺部轴调节。结果为 XEGMG 的保护作用提供了新的证据,这对易受感染的儿童有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1810/10088977/9a27415ddd0f/IPHB_A_2195884_F0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验